Lazard Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-621
Closed -$32K – 1905
2025
Q2
$32K Buy
621
+88
+17% +$4.83K ﹤0.01% 2071
2025
Q1
$32K Sell
533
-14,519
-96% -$936K ﹤0.01% 2067
2024
Q4
$1.03M Buy
15,052
+5,800
+63% +$404K ﹤0.01% 1138
2024
Q3
$665K Buy
9,252
+5,032
+119% +$355K ﹤0.01% 1266
2024
Q2
$292K Buy
4,220
+2,498
+145% +$182K ﹤0.01% 1436
2024
Q1
$137K Buy
+1,722
New +$153K ﹤0.01% 1426
2023
Q2
– Sell
-2,033
Closed -$211K – 2338
2023
Q1
$211K Buy
2,033
+1,247
+159% +$121K ﹤0.01% 1297
2022
Q4
$69K Hold
786
– – ﹤0.01% 1665
2022
Q3
$63K Hold
786
– – ﹤0.01% 1689
2022
Q2
$75K Sell
786
-45,834
-98% -$5.5M ﹤0.01% 1624
2022
Q1
$6.92M Sell
46,620
-10,182
-18% -$1.42M 0.01% 696
2021
Q4
$8.05M Buy
56,802
+56,441
+15,635% +$7.99M 0.01% 688
2021
Q3
$47K Buy
+361
New +$47.2K ﹤0.01% 1705
2021
Q2
– Sell
-3,485
Closed -$455K – 1975
2021
Q1
$455K Sell
3,485
-4,506
-56% -$542K ﹤0.01% 994
2020
Q4
$894K Buy
7,991
+7,658
+2,300% +$725K ﹤0.01% 910
2020
Q3
$26K Sell
333
-282
-46% -$23K ﹤0.01% 1364
2020
Q2
$44K Sell
615
-21,015
-97% -$1.46M ﹤0.01% 1257
2020
Q1
$1.24M Buy
21,630
+13,350
+161% +$1.23M ﹤0.01% 721
2019
Q4
$925K Buy
8,280
+1,615
+24% +$172K ﹤0.01% 758
2019
Q3
$640K Buy
6,665
+2,074
+45% +$195K ﹤0.01% 795
2019
Q2
$392K Buy
+4,591
New +$377K ﹤0.01% 964

Other funds holding CNMD

Lazard Asset Management's CNMD Position: Q3 2025 in Review

Lazard Asset Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 621 shares — an estimated $32K sold.

Lazard Asset Management first reported a position in CNMD in Q2 2019 and held it in 21 quarters. The position peaked at $8.05M in Q4 2021. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Lazard Asset Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 621 CONMED shares in Q3 2025, an estimated $32K.
  • Lazard Asset Management first reported a position in CONMED in Q2 2019 and held it in 21 quarters.
  • Lazard Asset Management's CONMED position peaked at $8.05M in Q4 2021.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.